FEB 21, 2020 8:33 AM PST

New Antibiotics Found Using AI Technology

WRITTEN BY: Annie Lennon

Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. 

Current methods for identifying antibiotics are both extremely costly, take a lot of time, and are typically limited to a narrow range of chemical diversity. To resolve this issue, researchers at MIT developed a machine-learning computer model capable of examining molecular structures of compounds to see whether they may be able to kill certain bacteria. 

To do this, they first trained a deep learning algorithm to recognize different types of molecules that kill bacteria by feeding it information on the atomic and molecular characteristics of almost 2,500 drugs and natural compounds. Alongside this, they added data on how well or not each substance prevented the growth of E coli. Bacteria. 

Following this, the scientists then used the algorithm to analyze over 6,000 compounds currently under investigation for treating various human diseases. Instead of looking for potential antimicrobials however, they instead focused the algorithm to find compounds that seemed effective, but did not resemble current antibiotics. In doing so, they wanted to find drug candidates capable of counteracting antibiotic resistance. 

Within just a few hours, the algorithm managed to find a promising antibiotic candidate: halicin, named after Hal, the astronaut-bothering AI in the 2001: A Space Odyssey. Testing the molecule on mice, the researchers noticed that it effectively ousted the gastrointestinal bug Clostridium difficile (C. diff), often the cause of fatal infections among hospitalized patients, as well as another antibiotic resistant bug, called Acinetobacter baumannii, known to cause infections in the blood, urinary tract and lungs. 

More than this, the scientists also tested halicin on bacteria collected from patients. In doing so, they found it also worked against Mycobacterium tuberculosis, the bacteria behind TB, and strains of Enterobacteriaceae, often responsible for diarrhoeal diseases. 

After this, the researchers set the algorithm on 107 million compounds from a database of 1.5 billion. WIthin three days, it managed to shortlist 23 potential antibiotics, from which two appear to be particularly useful. 

Now intending to search more of the database for possible drug candidates, the researchers hope they can find antibiotics that are more selective in the bacteria they kill; only killing infectious bugs, as opposed to healthy bacteria that live in the gut too. More than this, the researchers also hope that such computer models may soon be used to design new antibiotics from scratch. 

 


Sources: The Guardian, MIT News and The Conversation 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 21, 2020
Drug Discovery & Development
Metformin Does Not Work in All Type 2 Diabetics
SEP 21, 2020
Metformin Does Not Work in All Type 2 Diabetics
Although metformin is the first-line drug for type-2 diabetics, research shows that it is not always effective for all t ...
OCT 01, 2020
Cancer
Understanding in vivo Metabolomics: C13 Isotope Studies
OCT 01, 2020
Understanding in vivo Metabolomics: C13 Isotope Studies
One key to understanding cancer metabolomics lies in the ability to accurately replicate the natural environment of the ...
OCT 12, 2020
Cannabis Sciences
Can Cannabis Relieve Symptoms of Down Syndrome?
OCT 12, 2020
Can Cannabis Relieve Symptoms of Down Syndrome?
Increasing anecdotal and academic evidence has been emerging in recent years about the plethora of health benefits behin ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 08, 2020
Cell & Molecular Biology
Mouth Spray for Epidermolysis Bullosa in Development
NOV 08, 2020
Mouth Spray for Epidermolysis Bullosa in Development
Epidermolysis Bullosa (EB) is a rare genetic disorder that makes the skin incredibly fragile; it forms blisters and can ...
NOV 26, 2020
Cardiology
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
NOV 26, 2020
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
Cardiovascular disease and diabetes are often associated with each other, as many issues caused by diabetes promote hear ...
Loading Comments...